Leukocyte receptors for lipid and peptide mediators
Goetzl, E.J.
Federation Proceedings 46(1): 190-191
1987
ISSN/ISBN: 0014-9446 PMID: 3803613 Document Number: 305350
Document emailed within 1 workday
Related Documents
Perez, H.D.; Elfman, F.; Lobo, E. 1987: Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis Journal of Immunology 139(6): 1978-1984Windler, E. 1987: Lipoprotein receptors of the liver. Pivotal mediators of lipid metabolism Fortschritte der Medizin 105(36): 716-718
Pankov, I.A. 2005: The role of leptin and its peptide mediators in neurophysiology Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2005(2): 44-48
Christophe, J.; Waelbroeck, M.; Robberecht, P. 1982: Hormone and neuroeffector receptors in gastroenterology. a concrete example: the VIP (vasoactive intestinal peptide) receptors Acta Gastro-Enterologica Belgica 45(7-8): 280-291
Pretolani, M.; Vargaftig, B.B. 1991: Role of lipid mediators in allergic reactions Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 185(1-2): 37-45
Lefer, A.M. 1989: Significance of lipid mediators in shock states Circulatory Shock 27(1): 3-12
DeVries, G.W.; Jacobs, R.S. 1995: Poster discussion lipid mediators--new agents Agents and Actions. Supplements 47: 203-205
Endo, J.; Arita, M. 2011: Roles of lipid mediators in controlling vascular inflammation and the progression of atherosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 69(1): 34-38
Smith, F.L.; Welch, S.P.; Dombrowski, D.S.; Dewey, W.L. 1993: The role of endogenous opioids as mediators of the hypothermic effects of intrathecally administered calcium and calcitonin gene-related peptide in mice Journal of Pharmacology and Experimental Therapeutics 266(3): 1407-1415
Mathison, R.D.; Sank, C.; Davison, J.S. 1999: Inhibition of leukocyte rolling by submandibular gland peptide-T (SGP-T) Proceedings of the Western Pharmacology Society 42: 39-40
Massagué, J.; Weis-Garcia, F. 1996: Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals Cancer Surveys 27: 41-64
Levy, B.D.; Serhan, C.N. 2003: Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin-triggered lipid mediators Drugs of Today 39(5): 373-384
Sheval'e, A.F.; Samukov, V.V.; Ofitserov, V.I.; Kalashnikov, V.V.; Mizenko, G.A.; Kolokol'tsov, A.A. 1990: Immunochemical and biological properties of synthetic peptide fragments from the 124-144 sequence of human leukocyte interferon alpha2 Bioorganicheskaia Khimiia 16(7): 916-925
Perez, H.D.; Ong, R.; Khanna, K.; Banda, D.; Goldstein, I.M. 1982: Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis Journal of Immunology 129(6): 2718-2724
Rajaniemi, H.J.; Metsikkö, K. 1981: Peptide hormone receptors Duodecim; Laaketieteellinen Aikakauskirja 97(18): 1519-1533
Van der Saag, P.T. 1996: Nuclear retinoid receptors: mediators of retinoid effects European Journal of Clinical Nutrition 50(Suppl 3): S24-S28
Kalra, S. 2013: Glucagon-like peptide-1 receptors agonists (GLP1 RA) Jpma. Journal of the Pakistan Medical Association 63(10): 1312-1315
Tsybikov, N.N.; Kuznik, B.I.; Lozhkina, A.N.; Kradenov, A.V. 1985: Development of a high fibrinolytic potential around a thrombus using leukocyte Fc receptors loaded with streptase Biulleten' Eksperimental'noi Biologii i Meditsiny 100(11): 581-583
Pandey, G.N.; Janicak, P.G.; Pandey, S.C.; Davis, J.M. 1989: Effect of treatment with antidepressants and neuroleptics on human leukocyte beta-adrenergic receptors Psychopharmacology Bulletin 25(2): 257-262
Isturiz, M.A.; Giordano, M.; Geffner, J.R.; Palermo, M.S.; Serebrinsky, G. 1989: Interaction of immune complexes and their leukocyte receptors: regulation by the complement system and by cyclophosphamide Medicina 49(2): 140-146